Cargando…
Pruritus Reduction with Systemic Anti-lymphoma Treatments in Patients with Cutaneous T Cell Lymphoma: A Narrative Review
Cutaneous T-cell lymphomas (CTCL) are a heterogeneous and relatively rare group of non-Hodgkin lymphomas arising from neoplastic skin-homing memory T cells. There is no known cure for CTCL, and current treatments focus on achieving and maintaining remission, controlling symptoms, limiting toxicities...
Autores principales: | Field, Halle, Gao, Ling, Motwani, Pooja, Wong, Henry K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120632/ https://www.ncbi.nlm.nih.gov/pubmed/27590615 http://dx.doi.org/10.1007/s13555-016-0143-4 |
Ejemplares similares
-
Erratum to: Pruritus Reduction with Systemic Anti-lymphoma Treatments in Patients with Cutaneous T Cell Lymphoma: A Narrative Review
por: Field, Halle, et al.
Publicado: (2016) -
Lokivetmab improved pruritus in a dog with cutaneous epitheliotropic lymphoma
por: INAI, Kiyohiko, et al.
Publicado: (2021) -
Aprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literature
por: Song, Johanna S., et al.
Publicado: (2017) -
Interleukin-31 is overexpressed in skin and serum in cutaneous T-cell lymphomas but does not correlate to pruritus
por: Olszewska, Berenika, et al.
Publicado: (2020) -
Developing BET-ter treatments for cutaneous T-cell lymphoma
por: Wong, Henry K.
Publicado: (2019)